WallStSmart
IMCR

Immunocore Holdings Ltd

NASDAQ: IMCR · HEALTHCARE · BIOTECHNOLOGY

$27.92
-3.02% today

Updated 2026-04-29

Market cap
$1.42B
P/E ratio
P/S ratio
3.55x
EPS (TTM)
$-0.71
Dividend yield
52W range
$27 – $41
Volume
0.4M

WallStSmart proprietary scores

43
out of 100
Grade: D
Sell
Investment rating
9.3
Growth
A+
5.0
Quality
C+
2.5
Profitability
F
5.3
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$63.86
+128.72%
12-Month target
Intrinsic (DCF)
$33.76
Margin of safety
+2.46%
1 Strong Buy10 Buy4 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 24.30% QoQ
Risks
- Thin margins at -8.88%
- Negative free cash flow $-35.53M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$144.23M$197.39M$247.98M$297.57M$400.02M
Net income$-43.46M$-43.75M$-40.81M$-26.42M$-22.28M
EPS$-0.71
Free cash flow$-51.41M$-1.97M$20.89M$-11.20M$-35.53M
Profit margin-30.13%-22.17%-16.45%-8.88%-8.88%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
IMCR$1.42B439.32.55.35.0+2.46%Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Immunocore Holdings Ltd trades at $27.92. Our Smart Value Score of 43/100 indicates the stock is fair. TTM revenue stands at $400.02M. with profit margins at -8.88%. Our DCF model estimates intrinsic value at $33.76.

Frequently asked questions

What is Immunocore Holdings Ltd's stock price?
Immunocore Holdings Ltd (IMCR) trades at $27.92.
Is Immunocore Holdings Ltd overvalued?
Smart Value Score 43/100 (Grade D, Sell). DCF value $33.76.
What is the price target of Immunocore Holdings Ltd (IMCR)?
The analyst target price is $63.86, representing +128.7% upside from the current price of $27.92.
What is the intrinsic value of Immunocore Holdings Ltd (IMCR)?
Based on our DCF model, intrinsic value is $33.76, a +2.5% margin of safety versus $27.92.
What is Immunocore Holdings Ltd's revenue?
TTM revenue is $400.02M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio3.55x
ROE-9.58%
Beta0.83
50D MA$31.19
200D MA$33.57
Shares out0.05B
Float0.05B
Short ratio
Avg volume0.4M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years